266 related articles for article (PubMed ID: 35956124)
1. PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment.
Morgante G; Darino I; Spanò A; Luisi S; Luddi A; Piomboni P; Governini L; De Leo V
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956124
[TBL] [Abstract][Full Text] [Related]
2. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
[TBL] [Abstract][Full Text] [Related]
3. [Vitamin D and Polycystic Ovary Syndrome].
Lazúrová I; Figurová J; Dravecká I
Vnitr Lek; 2016; 62(9 Suppl 3):87-91. PubMed ID: 27734698
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D improves in-vitro fertilization outcomes in infertile women with polycystic ovary syndrome and insulin resistance.
Zhao J; Liu S; Wang Y; Wang P; Qu D; Liu M; Ma W; Li Y
Minerva Med; 2019 Jun; 110(3):199-208. PubMed ID: 30612423
[TBL] [Abstract][Full Text] [Related]
6. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
Velija-Ašimi Z
Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
[TBL] [Abstract][Full Text] [Related]
8. Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review.
Irani M; Merhi Z
Fertil Steril; 2014 Aug; 102(2):460-468.e3. PubMed ID: 24933120
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation inhibits NF-kß signaling pathway in lean and obese women with PCOS.
Ağar M; Güngör K; Güngör ND; Kavrut M; Madenli AA
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3973-3977. PubMed ID: 35731068
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D improves levels of hormonal, oxidative stress and inflammatory parameters in polycystic ovary syndrome: a meta-analysis study.
Zhao JF; Li BX; Zhang Q
Ann Palliat Med; 2021 Jan; 10(1):169-183. PubMed ID: 33545754
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D, PCOS and androgens in men: a systematic review.
Trummer C; Pilz S; Schwetz V; Obermayer-Pietsch B; Lerchbaum E
Endocr Connect; 2018 Mar; 7(3):R95-R113. PubMed ID: 29449314
[TBL] [Abstract][Full Text] [Related]
14. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.
Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A
Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295
[TBL] [Abstract][Full Text] [Related]
15. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
17. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
18. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
He C; Lin Z; Robb SW; Ezeamama AE
Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
20. Differential Impact of Insulin Sensitizers vs. Anti-Androgen on Serum Leptin Levels in Vitamin D Replete PCOS Women: A Six Month Open Labeled Randomized Study.
Rashid A; Ganie MA; Wani IA; Bhat GA; Shaheen F; Wani IA; Shrivastava M; Shah ZA
Horm Metab Res; 2020 Feb; 52(2):89-94. PubMed ID: 32053841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
